The DOI matches its Crossref record; the references it cites are not checked yet.
The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease
Open accessAbstract
Multiple myeloma (MM) is an osteolytic malignancy that is incurable due to the emergence of treatment resistant disease. Defining how, when and where myeloma cell intrinsic and extrinsic bone microenvironmental mechanisms cause relapse is challenging with current biological approaches. Here, we report a biology-driven spatiotemporal hybrid agent-based model of the MM-bone microenvironment. Results indicate MM intrinsic mechanisms drive the evolution of treatment resistant disease but that the protective effects of bone microenvironment mediated drug resistance (EMDR) significantly enhances the probability and heterogeneity of resistant clones arising under treatment. Further, the model predicts that targeting of EMDR deepens therapy response by eliminating sensitive clones proximal to stroma and bone, a finding supported by in vivo studies. Altogether, our model allows for the study of MM clonal evolution over time in the bone microenvironment and will be beneficial for optimizing treatment efficacy so as to significantly delay disease relapse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In multiple myeloma, mesenchymal stem cells (MSCs) play a role in the development of osteolytic bone lesions by promoting osteoclastogenesis [4].”
From Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword (2025) · cites this paper as [4]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 112 · Cited by 16
Research works printed but not linked: 3
- Howlader N. N. A., et al. SEER Cancer Statistics Review, 1975-2016, National Cancer Institute. (2019).
- Chen, S. et al. A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis). American Society of Hematology Washington, DC (2014). · DOI
- Bishop, R. T. et al. The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease. Open Science Framework, https://doi.org/10.17605/OSF.IO/TNAX17609. (2023). · doi:10.17605/osf.io/tnax17609
Metadata
- Authors
- Bishop, R. T., Miller, A. K., Froid, M., Nerlakanti, N., Li, T., Frieling, J. S., Nasr, M. M., Nyman, K. J., Sudalagunta, P. R., Canevarolo, R. R., Silva, A. S., Shain, K. H., Lynch, C. C., & Basanta, D.
- Affiliations
- Moffitt Cancer Center (US)
- University of South Florida (US)
- Corresponding author
- Lynch, Conor C.
- Basanta, David
- ORCID
- Venue
- Nature Communications
- Published
- 2024-03-19
- Volume
- 15
- Issue
- 1
- Pages
- 2458-2458
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC10951361
- OpenAlex
- W4392953430
- Cited by
- 16
- References
- 112
- Citations by year
- 2026: 9 · 2025: 3 · 2024: 4
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Moffitt Cancer Center (P30CA076292, CA076292)
- National Cancer Institute (U54CA193489, CA076292, U01CA244101, P30CA076292)
- Topics
- Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone Tumor Diagnosis and Treatments
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- multiple myeloma, bone microenvironment, recurrence, drug resistance, clonal evolution, stromal microenvironment, agent-based modeling, spatio-temporal modeling, treatment response, osteolytic bone disease
- MeSH terms
- Bone and Bones, Chronic Disease, Drug Resistance, Humans, Multiple Myeloma, Neoplasm Recurrence, Local, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease. https://app.cochat.ai/papers/10.1038/s41467-024-46594-0
- The paper
- Bishop, R. T., Miller, A. K., Froid, M., Nerlakanti, N., Li, T., Frieling, J. S., Nasr, M. M., Nyman, K. J., Sudalagunta, P. R., Canevarolo, R. R., Silva, A. S., Shain, K. H., Lynch, C. C., & Basanta, D. (2024). The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease. Nature Communications. https://doi.org/10.1038/s41467-024-46594-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.